Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
SLC9A3 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 |
5p15.3 |
1(1/0/0)
|
TAS
|
CHRNA2 |
cholinergic receptor, nicotinic, alpha 2 (neuronal) |
8p21 |
3(0/3/0)
|
NAS[8906617]
|
SLC1A4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
2p15-p13 |
1(0/1/0)
|
TAS
|
SLC12A6 |
solute carrier family 12 (potassium/chloride transporter), member 6 |
15q13 |
1(1/0/0)
|
IDA[10187864]; TAS
|
SLC20A1 |
solute carrier family 20 (phosphate transporter), member 1 |
2q13 |
1(0/1/0)
|
TAS
|
SLC22A23 |
solute carrier family 22, member 23 |
6p25.2 |
1(1/0/0)
|
IEA
|
GLRA1 |
glycine receptor, alpha 1 |
5q33.1 |
1(1/0/0)
|
IDA[2155780]
|
SLC15A1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
13q32.3 |
1(0/1/0)
|
TAS
|
CHRNA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
20q13.33 |
1(1/0/0)
|
NAS[8906617]
|
MLC1 |
megalencephalic leukoencephalopathy with subcortical cysts 1 |
22q13.33 |
5(1/4/0)
|
IEA
|
CHRNA3 |
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
15q24 |
3(1/2/0)
|
NAS[8906617]
|
SLC1A2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
11p13-p12 |
1(1/0/0)
|
TAS
|
CNNM4 |
cyclin and CBS domain divalent metal cation transport mediator 4 |
2q11.2 |
1(1/0/0)
|
IEA
|
CHRNB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
1q21.3 |
1(1/0/0)
|
NAS[8906617]
|
CHRNA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
15q13.3 |
4(2/2/0)
|
NAS[8906617]
|
SLC1A1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
9p24 |
1(1/0/0)
|
TAS
|
GABRB1 |
gamma-aminobutyric acid (GABA) A receptor, beta 1 |
4p12 |
3(2/0/1)
|
ISS
|
CHRNB4 |
cholinergic receptor, nicotinic, beta 4 (neuronal) |
15q24 |
2(1/1/0)
|
TAS[8906617]
|